Results 31 to 40 of about 436,688 (335)

Inhibition of hydrogen sulfide biosynthesis sensitizes lung adenocarcinoma to chemotherapeutic drugs by inhibiting mitochondrial DNA repair and suppressing cellular bioenergetics [PDF]

open access: yes, 2016
Therapeutic manipulation of the gasotransmitter hydrogen sulfide (H(2)S) has recently been proposed as a novel targeted anticancer approach. Here we show that human lung adenocarcinoma tissue expresses high levels of hydrogen sulfide (H(2)S) producing ...
Druzhyna, Nadiya   +7 more
core   +1 more source

Retracted: Screening of Key Prognosis Genes of Lung Adenocarcinoma Based on Expression Analysis on TCGA Database

open access: yesJournal of Oncology, 2023
[This retracts the article DOI: 10.1155/2022/4435092.].
Journal of Oncology
semanticscholar   +1 more source

miR-625-5p promotes proliferation and invasion of lung adenocarcinoma by targeting PRKACA [PDF]

open access: yesZhongguo aizheng zazhi, 2021
Background and purpose: Lung adenocarcinoma is a subtype of non-small cell lung cancer. Although much progress has been made in the diagnosis and treatment of lung adenocarcinoma, the clinical prognosis and overall survival of advanced lung  ...
HU Yaqiong , BAI Jun , CHEN Lin , CHEN Xinlu , ZHANG Liping , ZHOU Dandan , WANG Yu , YIN Chonggao , LI Hongli , LIU Yuqing
doaj   +1 more source

Retracted: Expression of CX3CL1 and CCL28 in Spinal Metastases of Lung Adenocarcinoma and Their Correlation with Clinical Features and Prognosis

open access: yesJournal of Healthcare Engineering, 2023
[This retracts the article DOI: 10.1155/2022/2580419.].
Journal of Healthcare Engineering
semanticscholar   +1 more source

Effective osimertinib treatment in a patient with discordant T790 M mutation detection between liquid biopsy and tissue biopsy. [PDF]

open access: yes, 2018
BACKGROUND:We report the successful treatment of the patient with osimertinib 80 mg/day following disease progression and a discordance in the detection of a mechanism of resistance epithelial growth factor receptor (EGFR) T790 M between liquid biopsy ...
Mambetsariev, Isa   +3 more
core   +1 more source

Pan-cancer classifications of tumor histological images using deep learning [PDF]

open access: yes, 2020
Histopathological images are essential for the diagnosis of cancer type and selection of optimal treatment. However, the current clinical process of manual inspection of images is time consuming and prone to intra- and inter-observer variability. Here we
Caruana, Dennis   +8 more
core   +1 more source

Follistatin is a novel biomarker for lung adenocarcinoma in humans. [PDF]

open access: yesPLoS ONE, 2014
Follistatin (FST), a single chain glycoprotein, is originally isolated from follicular fluid of ovary. Previous studies have revealed that serum FST served as a biomarker for pregnancy and ovarian mucinous tumor.
Fangfang Chen   +7 more
doaj   +1 more source

Retracted: The Effect of lncRNA SNHG3 Overexpression on Lung Adenocarcinoma by Regulating the Expression of miR-890

open access: yesJournal of Healthcare Engineering, 2023
[This retracts the article DOI: 10.1155/2021/1643788.].
Journal of Healthcare Engineering
semanticscholar   +1 more source

Modulation of 5-Aminolevulinic acid mediated photodynamic therapy induced cell death in a human lung adenocarcinoma cell line [PDF]

open access: yes, 2016
Photodynamic therapy (PDT) is a cancer treatment involving the administration of a photosensitising drug which selectively accumulates in tumor tissue, followed by irradiation with appropriate wavelength light.
Battle, A.   +3 more
core   +2 more sources

XXYLT1 methylation contributes to the occurrence of lung adenocarcinoma

open access: yesMedicine, 2021
Abstract Background: There is evidence that DNA methylation play major roles in lung cancer. In our previously study, C3 or f21 , also referred to as XXYLT1, rs2131877 polymorphism is associated with a reduced risk of lung adenocarcinoma. So, we explored the role of XXYLT1 methylation in lung adenocarcinoma.
Zeng, Hui   +3 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy